Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash & Current Investments (2021 - 2025)

PAVmed (PAVM) has 5 years of Cash & Current Investments data on record, last reported at $299000.0 in Q3 2025.

  • For Q3 2025, Cash & Current Investments changed N/A year-over-year to $299000.0; the TTM value through Jun 2025 reached $4.3 million, down 83.12%, while the annual FY2024 figure was $1.5 million, 92.44% down from the prior year.
  • Cash & Current Investments reached $299000.0 in Q3 2025 per PAVM's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $77.3 million in Q4 2021 and bottomed at $299000.0 in Q3 2025.
  • Average Cash & Current Investments over 5 years is $33.8 million, with a median of $37.2 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 52.07% in 2022, then plummeted 92.44% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $77.3 million in 2021, then plummeted by 48.56% to $39.7 million in 2022, then plummeted by 50.59% to $19.6 million in 2023, then tumbled by 92.44% to $1.5 million in 2024, then tumbled by 79.85% to $299000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $299000.0 in Q3 2025, $4.3 million in Q2 2025, and $3.0 million in Q1 2025.